Human T-lymphotropic virus 2
Human T-lymphotropic virus 2 | |
---|---|
Specialty | Infectious diseases |
Symptoms | Mild cognitive Impairment, Mycosis fungoides |
Duration | Chronic, incurable |
Causes | HTLV-2 |
Risk factors | Unsafe sex, haemophiliacs |
Diagnostic method | Blood test |
Differential diagnosis | HIV/AIDS, Lymphoma, HTLV-1 |
Prevention | Practicing safe-sex, use of clean needles, screening blood transfusions, Avoiding breastfeeding. |
Medication | Antiretrovirals, chemotherapy |
Prognosis | 95% present with no symptoms, generally good |
Frequency | 15-20 million people worldwide |
Primate T-lymphotropic virus 2 | |
---|---|
Virus classification | |
(unranked): | Virus |
Realm: | Riboviria |
Kingdom: | Pararnavirae |
Phylum: | Artverviricota |
Class: | Revtraviricetes |
Order: | Ortervirales |
Family: | Retroviridae |
Genus: | Deltaretrovirus |
Species: | Primate T-lymphotropic virus 2
|
A
HTLV-2 is prevalent among the indigenous populations in Africa and the Indian-American tribes in Central and South America as well as among drug users in Europe and North America[3] It can be passed down from mother to child through breastmilk and genetically as well from either parent.
HTLV-II entry in target cells is mediated by the glucose transporter GLUT1.[4]
Virology
Transmission
Perinatal transmission and breastfeeding and through blood transfusion, sexual contact, and use of intravenous drugs.[3]
Epidemiology
HTLV-1 and HTLV-2 are both involved in actively spreading epidemics, affecting 15-20 million people worldwide. [4] In the United States, the overall prevalence is 22 per 100,000 population, with HTLV-2 more common than HTLV-1. Data collection performed from 2000 to 2009 among US blood donors has shown a general decline since the 1990s.[6]
Symptoms
Human T- leukemia, type 2 (HTLV-2) generally causes no signs or
- Sensory neuropathies (conditions that affect the nervesthat provide feeling)
- Gait abnormalities
- Bladderdysfunction
- Mild cognitive impairment
- Motor abnormalities (loss of or limited muscle control or movement, or limited mobility)
- Erectile dysfunction
- Mycosis fungoides
Although evidence is limited, there may also be a link between HTLV-2 and chronic lung infections (i.e. pneumonia and bronchitis), asthma and dermatitis.[8]
Clinical significance
HTLV-II has not been clearly linked to any disease, but has been associated with several cases of
]An impact on platelet count has been observed.[9]
In the 1980s, HTLV-2 was identified in a patient with an unidentified T cell
Treatment
There are few
Diagnosis
Human T- leukemia, type 2 (HTLV-2) is usually diagnosed based on blood tests that detect to the virus. However, HTLV-2 is often never suspected or diagnosed since most people never develop any signs or symptoms of the infection. Diagnosis may occur during for blood donation, testing performed due to an infection, or a work-up for an HTLV-2-associated medical problems.[8]
Prevention
Due to there being no cure for HTLV II the prevention is focused on early detection and preventing the spread of HTLV-2 to others. blood donors, promoting safe sex and discouraging needle sharing can decrease the number of new infections. Mother-to-child transmission can be reduced by screening pregnant women so infected mothers can avoid breastfeeding.[8]
Prognosis
The long-term outlook for most people infected with HTLV-2 is good. Infection with HTLV-2 is lifelong, but 95% of affected people have no signs or symptoms of the condition. Although, HTLV-2-related health problems tend to be significantly milder than those associated with HTLV1.[8]
References
- ^ PMID 20692726.
- ^ "Robert gallo discovers htlv2 and 1". Retrieved 23 February 2019.
- ^ PMID 25120538.
- PMID 14622599.
- ^ a b "Journal of the American Academy of Dermatology". www.jaad.org. Retrieved 2019-02-22.
- ^ a b "Human T-Cell Lymphotropic Viruses (HTLV)". Medscape. Retrieved 22 February 2019.
- ^ "HTLV Type I and Type II". NORD (National Organization for Rare Disorders). Retrieved 2019-02-22.
- ^ a b c d e "Human T-cell leukemia virus type 2". US Department of Health and Human Services | Genetic and Rare Diseases Information Center (GARD) – an NCATS Program. Retrieved 2019-02-22. This article incorporates text from this source, which is in the public domain.
- PMID 18755983.
- PMID 6981847.
- PMID 2827811. Retrieved 10 July 2020.
- PMID 17376384.
External links
- "Human T-lymphotropic virus 2". NCBI Taxonomy Browser. 11909.
- International Retrovirology Association
- Human+T-lymphotropic+virus+2 at the U.S. National Library of Medicine Medical Subject Headings (MeSH)